000 01202 a2200361 4500
005 20250513035051.0
264 0 _c19930719
008 199307s 0 0 eng d
022 _a0012-1797
024 7 _a10.2337/diab.42.7.941
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEisenbarth, G S
245 0 0 _aThe design of trials for prevention of IDDM.
_h[electronic resource]
260 _bDiabetes
_cJul 1993
300 _a941-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aClinical Trials as Topic
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aGlucose Tolerance Test
650 0 4 _aHumans
650 0 4 _aInsulin
_xblood
650 0 4 _aNiacinamide
_xtherapeutic use
650 0 4 _aPilot Projects
650 0 4 _aPrediabetic State
_xdrug therapy
650 0 4 _aResearch Design
650 0 4 _aRisk Factors
650 0 4 _aTreatment Outcome
700 1 _aVerge, C F
700 1 _aAllen, H
700 1 _aRewers, M J
773 0 _tDiabetes
_gvol. 42
_gno. 7
_gp. 941-7
856 4 0 _uhttps://doi.org/10.2337/diab.42.7.941
_zAvailable from publisher's website
999 _c7646014
_d7646014